Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
6.47M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
74.3K
-
Shares change
-
-39.6K
-
Total reported value, excl. options
-
$70.9K
-
Value change
-
-$51.4K
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$0.96
Significant Holders of MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) as of Q2 2025
17 filings reported holding MBIO - MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value as of Q2 2025.
MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.3K shares
of 6.47M outstanding shares and own 1.15% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (28.1K shares), UBS Group AG (22.6K shares), GEODE CAPITAL MANAGEMENT, LLC (16.1K shares), Tower Research Capital LLC (TRC) (3.98K shares), BlackRock, Inc. (1.67K shares), CITIGROUP INC (1.01K shares), SBI Securities Co., Ltd. (502 shares), MORGAN STANLEY (237 shares), HARBOUR INVESTMENTS, INC. (76 shares), and BANK OF AMERICA CORP /DE/ (33 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.